Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 56.2B | 59.5B | 57.0B | 61.1B |
| Cost of revenue | 47.9B | 48.6B | 51.1B | 51.5B |
| Gross profit | 8.4B | 10.9B | 5.9B | 9.6B |
| Operating expense | ||||
| Research & development | 239.0M | 159.0M | 284.6M | 252.8M |
| Selling general and admin | 2.6B | 2.4B | 2.8B | 2.7B |
| Other operating expenses | 309.5M | 180.5M | 739.3M | 262.2M |
| Operating income | 5.2B | 8.1B | 2.1B | 6.4B |
| Non operating interest income | ||||
| Income | 516.7M | 486.6M | 159.0M | 668.8M |
| Expense | 924.2M | 962.9M | 1.1B | 1.0B |
| Other income expense | — | — | — | — |
| Pretax income | 5.1B | 7.7B | 3.6B | 6.3B |
| Tax provision | 2.0B | 3.5B | 2.7B | 2.5B |
| Net income | 3.1B | 4.2B | 894.9M | 3.8B |
| Basic EPS | 1.2 | 1.6 | 0.3 | 1.4 |
| Diluted EPS | 1.2 | 1.6 | 0.3 | 1.4 |
| Basic average shares | 2.6B | 2.6B | 2.6B | 2.7B |
| Diluted average shares | 2.6B | 2.6B | 2.7B | 2.7B |
| EBITDA | 10.6B | 13.5B | 7.8B | 12.5B |
| Net income from continuing op. | 5.1B | 7.7B | 3.6B | 6.3B |
| Minority interests | -37.0M | -81.7M | -97.1M | -86.0M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |